World Market for Personalized Medicine Diagnostics (Biomarkers, Pharmacodiagnostics, Tumor Assays, Cardiac Risk and Other Testing)

A special focus of the report is the bustle of activity with collaborations between IVD and pharmaceutical companies, as well as IVD companies and CLIA labs. This report profiles scores of such companies operating in this market and estimates and forecasts markets (where there are products on the market) for personalized medicine technologies in the following categories:
•    Cardiac Markers, immunoassays
•    Cardiac Risk Markers
•    Cardiac markers, molecular
•    Coagulation, routine
•    Coagulation, molecular
•    Cancer, Tumor Markers
•    Cancer, Molecular
•    Cancer, Tissue-based
•    Psychiatric Disorders
•    Diabetes, BGM
•    Diabetes, HbA1c
•    Microbiology, ID/AST
•    Infectious Diseases, Viral Load (HIV, HCV, HBV)
•    Infectious Diseases, other
•    Blood Bank Molecular
•    Transplant Tissue Typing
•    Lab Developed Tests

Global Personalized Medicine Diagnostics Market

Published: March 2012
No. of Pages:  430
Price: Single User License – US$3795              Corporate User License – US$7590 
 

In this market research report, Kalorama Information defines the current opportunity and a realistic future potential for personalized medicine in clinical testing. In addition to analysis of tests currently on the market and in development, the report profiles key competitors and discusses trends that are important for understanding this much-discussed growth area of the diagnostic industry.
Developments that are linked in the press to 'personalized medicine' are many, and can at times be confusing. But there are several discovered biomarkers that are important in diagnostic markets.

Biomarkers discussed in the report include:
•    Cytochrome P450 and Drug Metabolism
•    Estrogen Receptor and Progesterone
•    Receptor Status for Breast Cancer
•    HER2 Overexpression and Herceptin and Tykerb
•    Epidermal Growth Factor Receptor (EGFR)
•    KRAS Mutations and Anti-EGFR Therapy for Colorectal Cancer
•    BRAF Mutations and Cancer Therapy
•    UGT1A1 Genetic Variants
•    5-Flurouracil Therapy
•    PIK3CA Genetic Variation
•    KIF6 Genetic Variation
•    ALK Genetic Variation

Major points covered in Table of Contents of this report include:
•    CHAPTER ONE: EXECUTIVE SUMMARY
•    CHAPTER TWO: INTRODUCTION
•    CHAPTER THREE: STRATEGIC ISSUES: THE “COMMERCIALIZATION CONDUNDRUM”
•    CHAPTER FOUR: DISEASE TARGETS
•    CHAPTER FIVE: DIAGNOSTIC TECHNOLOGIES
•    CHAPTER SIX: MARKET ANALYSIS
•    CHAPTER SEVEN: CONCLUSIONS AND STRATEGIC IMPLICATIONS
•    CHAPTER EIGHT: COMPANY PROFILES
•    List of Tables

Explore Reports related to Biotechnology @ http://www.reportsnreports.com/market-research/biotechnology/

Cell Culture: The World Market for Media, Sera and Reagents, 3rd. Edition

Published: October 2011

No. of Pages: 155

Price: $ 3500

Several cell culture-derived biopharmaceutical drugs were launched in the US and European markets in 2010. Biopharmaceuticals (recombinant proteins, monoclonal antibody and nucleic acid-based products) represent the fastest growing sector in the pharmaceutical industry. Driving the extraordinary interest in biopharmaceuticals is the ability of these large proteins to target diseases in a very specific manner, thus maximizing efficacy while minimizing side effects.

Growth in the development and production of biopharmaceuticals is the most significant driver of the cell culture market. Biological products are developed from large and complex protein molecules, which require equally complex manufacturing methods and an array of analytical techniques. Protein-based biopharmaceuticals are invariably produced by an initial cell culture step (upstream processing), followed by product recovery, purification and formulation into final product format (downstream processing).

This report analyzes the world market for the cell cultures used in these steps and the major trends driving this market. Forecasts and current market sizing are provided in three specific segments:

• Media,

• Sera, and

• Reagents

Browse All: Biotechnology Market Research Reports

In addition to a thorough discussion of the technologies and techniques currently employed and emerging in the cell culture area, the Kalorama's exhaustive report provides specific information on:

• Market Size, growth, and forecasts of the segments through 2015

• Competitive Market Share by leading supplier as of 2010.

• Estimated Market Share by Region (North America, Europe, U.S.)

• Key Market Drivers and Restraints for suppliers, including discussions of biopharmaceutical pipelines, biomedical R&D directions, and the future of transgenic plant and animal production.

• Review of the various expression systems (Bacteria, Yeast, Insect, and Mammal) and the biopharmaceutical product manufactured by these systems

• Discussion of the preferences in media types vying for dominance in the market, including the following:

ADCF - animal derived component free media

CD - chemically defined media

CSFM - complete serum free medium

PF - protein free media

SF - serum free media

SFM - serum free medium

• Major Trends Impacting the Market stem cell research (including plans of major companies)cell culture-based vaccine Production and generic bipharmaceuticals

• Profiles of Leading Suppliers and information about M&A activities in recent years

The information for this report Cell Culture: The World Market for Media, Sera and Reagents, 3rd. Edition was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study Kalorama Information conducted interviews with key industry officials, consultants, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with pharmaceutical company and cell culture supply company representatives included marketing directors, division managers, and product representatives.

All Kalorama reports advertise the single user price, which limits access to one user. We also feature department and global pricing for reports that will be utilized by more than one user at your company. Please ask your sales representative or select the correct license on our website.